Tessari Eben bought KNSA
July 15, 2025 · Form 4 insider transaction
Tessari Eben bought 752 shares of Kiniksa Pharmaceuticals International, plc at $15.63 per share, a transaction worth $11.8K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 23 days after the transaction.
Direction
Acquired (buy-side)
Shares
752
Price
$15.63
Total value
$11.8K
InsiderTessari Eben
RoleOfficer
SecurityClass A Ordinary Share
Transaction codeA: Grant or award
Transaction dateJuly 15, 2025
Filing dateAugust 7, 2025
Shares owned after49,915
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The reporting person is voluntarily reporting the acquisition of these shares pursuant to the Issuer's 2018 Employee Share Purchase Plan for the purchase period of January 16, 2025 to July 15, 2025. The acquisition of these shares was exempt pursuant to Rule 16B-3(e).